案件核心信息 - Rosen Law Firm提醒在2024年3月7日至2025年5月23日期间购买Savara Inc (NASDAQ: SVRA) 证券的投资者，首席原告截止日期为2025年11月7日 [1] - 一项针对Savara的集体诉讼已被提起，指控公司在相关期间内作出了虚假和/或误导性陈述 [4] 诉讼指控细节 - 指控称，Savara的MOLBREEVI生物制剂许可申请缺乏关于其化学、制造和/或控制的充分信息，导致美国FDA不太可能批准其当前形式的申请 [4] - 上述问题使得Savara不太可能在其向投资者承诺的时间框架内完成MOLBREEVI BLA的提交，并且监管批准的延迟增加了公司需要筹集额外资金的可能性 [4] - 诉讼声称，当真实情况进入市场时，投资者遭受了损失 [4] 律所背景信息 - Rosen Law Firm专注于证券集体诉讼和股东衍生诉讼，其代表全球投资者 [3] - 该律所在2017年被ISS Securities Class Action Services评为证券集体诉讼和解数量第一名，自2013年以来每年排名前四，并为投资者追回数亿美元，其中2019年即为投资者获得超过4.38亿美元 [3]

Sep 23, 2025 7:20 PM Eastern Daylight Time SVRA NOTICE: Savara Inc. Investors Urged to Contact Kirby McInerney LLP About Securities Fraud Lawsuit Share NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds Savara Inc. ("Savara†or the "Company†) (NASDAQ:SVRA) investors of the November 7, 2025 deadline to seek lead plaintiff appointment in the class action filed on behalf of investors who acquired Savara securities between March 7, 2024 through May 23, 2025 ("the Class Period†). Follow th ...

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contact Us: Accessibility StatementSkip Navigation LOS ANGELES, Sept. 23, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SAVARA (SVRA), CLICK HERE BEFORE NOVEMBE ...

LOS ANGELES--(BUSINESS WIRE)--Savara Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SVRA. ...

NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA) and certain officers. ...

NEW YORK, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submissio ...

NEW YORK , Sept. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Savara Inc. (NASDAQ: SVRA). ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Savara To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Savara between March 7, 2024 and May 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIR ...

NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Savara Inc. (NASDAQ: SVRA) between March 7, 2024 and May 23, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 7, 2025. SO WHAT: If you purchased Savara securities during the Class Period y ...

Savara Inc. (NASDAQ:SVRA) is one of the best healthcare penny stocks to buy now. On September 9, Guggenheim raised its price target of the stock to $11 from $8 while reiterating a Buy rating. The price target hike follows an impressive 16% stock rally year to date. Guggenheim Lifts Savara (SVRA) Price Target on Pulmonary Alveolar Proteinosis Opportunity The research firm raised its price target, buoyed by positive developments that affirm long-term prospects. For starters, the company has achieved alignm ...